Vanda's Letter to FDA Commissioner Highlights Faulty Gastroparesis NDA Review
Go back to Vanda's Letter to FDA Commissioner Highlights Faulty Gastroparesis NDA Review| Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) | Delayed: 4.98 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.98 | 52 Week High | $18.00 | |||
| Open | $4.98 | 52 Week Low | $6.91 | |||
| Day High | $4.98 | P/E | N/A | |||
| Day Low | $4.98 | EPS | $-0.67 | |||
| Volume | 19,770 | |||||
